|
Market Closed -
Nasdaq
23:00:00 10/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 27.74 USD | +0.22% |
|
-0.43% | +3.86% |
| 08-25 | Deutsche Bank Adjusts ACADIA Pharmaceuticals PT to $38 From $37, Maintains Buy Rating | MT |
| 08-25 | EU Approves Acadia Pharmaceuticals' Rett Syndrome Drug Daybu | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ACAD | Delayed | |
CBOE
| ACAD | Real-time | |
|
Mexican S.E.
| ACAD * | End-of-day quote | |
|
Deutsche Boerse AG
| DR6 | Delayed | |
|
Tradegate
| DR6 | Real-time | |
|
Börse Stuttgart
| DR6 | Delayed | |
|
Boerse Muenchen
| DR6 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 30.57 | 30.57 | 29.5 |
| Spread/Res. | -9.26% | -9.26% | -5.97% |
| Spread/Supp. | +11.72% | +11.72% | +11.67% |
| Support | 24.83 | 24.83 | 24.84 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ACAD Stock
- Charts ACADIA Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
